This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: The University of New Mexico. Active years: 2019-2024.
Company Filing History:
Years Active: 2019-2024
Title: Matthias Barton: Innovator in Molecular Biology and Pharmacology
Introduction
Matthias Barton is a prominent inventor based in Zurich, Switzerland. He has made significant contributions to the fields of molecular biology and pharmacology. With a total of 4 patents to his name, Barton is recognized for his innovative approaches to treating various health conditions.
Latest Patents
One of Barton's latest patents focuses on a method for treating obesity, diabetes, cardiovascular, and kidney diseases by regulating GPR30/GPER activity. This invention provides methods for using compounds that modulate the effects of GPR30/GPER, particularly agonists for treating obesity and diabetes. Additionally, it addresses disease states resulting from excessive formation of reactive oxygen species, utilizing antagonists to counteract these effects. The compounds may function as both agonists and antagonists of the disclosed estrogen receptor, while also modulating the expression and upregulation of nox and nox-associated reactive oxygen species (ROS).
Career Highlights
Matthias Barton is affiliated with the University of New Mexico, where he continues to advance research in his field. His work has garnered attention for its potential impact on public health, particularly in addressing metabolic and cardiovascular diseases.
Collaborations
Barton has collaborated with notable colleagues, including Eric R Prossnitz and Matthias R Meyer. These partnerships have further enriched his research endeavors and contributed to the development of innovative solutions in healthcare.
Conclusion
Matthias Barton stands out as an influential inventor in the realm of molecular biology and pharmacology. His innovative patents and collaborative efforts reflect his commitment to improving health outcomes through scientific research.